Johnson & Johnson continues its $55 billion investment in U.S. operations (first announced back in 2025), targeting ...
32 Biosciences revealed its plan to launch a $40 million Series A at this year’s J.P Morgan Healthcare conference, to advance ...
In the third part of her conversation with PharmExec, Trialynx founder and CEO Angela Schwab discusses the causes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback